MedTrace Logo

Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

NCT00417014 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2013-08-02

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy, such as chlorambucil, vinblastine, procarbazine, and prednisolone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill cancer cells. Giving more than one drug (combination chemotherapy) together with radiation therapy may kill more cancer cells.

PURPOSE: This clinical trial is studying how well giving combination chemotherapy and/or radiation therapy works in treating young patients with Hodgkin's lymphoma.

Conditions

Interventions

DRUG

chlorambucil

DRUG

prednisolone

DRUG

procarbazine hydrochloride

DRUG

vinblastine sulfate

RADIATION

radiation therapy

Sponsors & Collaborators

  • Children's Cancer and Leukaemia Group

    lead OTHER

Principal Investigators

  • John Martin, MD · Royal Liverpool Children's Hospital, Alder Hey

  • A. Barratt, MD · Royal Marsden NHS Foundation Trust

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00417014 on ClinicalTrials.gov